Myocardial protection during coronary angioplasty

about

Myocardial protection during coronary angioplasty.

P2860

Q43139212-73E97979-A43A-41C9-BB27-3DDDF99200BE

P2860

Myocardial protection during coronary angioplasty

Item

http://www.wikidata.org/entity/Q35684768

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Myocardial protection during coronary angioplasty

@ast

Myocardial protection during coronary angioplasty

@en

type

Item

label

Myocardial protection during coronary angioplasty

@ast

Myocardial protection during coronary angioplasty

@en

prefLabel

Myocardial protection during coronary angioplasty

@ast

Myocardial protection during coronary angioplasty

@en

P1476

Myocardial protection during coronary angioplasty

@en

P2093

D R Leachman

http://www.w3.org/2001/XMLSchema#string

G Disciascio

http://www.w3.org/2001/XMLSchema#string

J A Brinker

http://www.w3.org/2001/XMLSchema#string

M J Cowley

http://www.w3.org/2001/XMLSchema#string

P Angelini

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.

Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

New balloon catheter for prolonged percutaneous transluminal coronary angioplasty and bypass flow in occluded vessels.

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous T

The coronary sinus: an alternate channel for administration of arterial blood and pharmacologic agents for protection and treatment of acute cardiac ischemia.

Flow characteristics of coronary balloon catheters.

Perfusion balloon catheter.

Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.

Predictors, therapeutic options and long-term outcome of abrupt reclosure.

"High-risk" percutaneous transluminal coronary angioplasty with preventive intra-aortic balloon counterpulsation.

P304

112-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15227423

http://www.w3.org/2001/XMLSchema#string

P932

326266

http://www.w3.org/2001/XMLSchema#string

Myocardial protection during coronary angioplasty

about

P2860

P2860

Myocardial protection during coronary angioplasty

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932